Policy | May 07, 2026
Danone India and UP govt. introduce Iron-Anthem to drive anemia awareness
The 40-second film brings children to the forefront of the narrative
The 40-second film brings children to the forefront of the narrative
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
Emcure has launched an awareness campaign to help spread the word about male anemia
The study observed 2,648 girls, of which 2,300 completed the standard 45-day programme
Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients
MabionCD20 is a monoclonal antibody originally developed by Mabion as a biosimilar candidate to MabThera and Rituxan therapies
Funding will support the expansion of Remidio’s Oculomics platform to identify early signs of pre-eclampsia, anemia and gestational diabetes through retinal imaging, targeting underserved communities
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
